Condition
Prostate Cancer Metastatic Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Prostate Cancer Metastatic Disease clinical trials that are recruiting, at sites in 4 countries (most in United States (5), France (2), China (2)). By phase: Phase 2 (4), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 4Countries
Newest Prostate Cancer Metastatic Disease clinical trials
All recruiting trials (10)
-
PSMA-targeted fluorescent dye OTL78 to guide prostate cancer surgery
This study tests whether the PSMA-targeted fluorescent dye OTL78, used with near-infrared imaging, can help doctors better find and remove prostate cancer tissue during surgery in men with confirmed prostate cancer.
-
Using PSMA PET with MRI to watch for prostate cancer returning after focal therapy
We will try adding a PSMA PET scan to routine MRI follow-up to see if it finds prostate cancer coming back sooner in men who had focal (partial gland) therapy.
-
Mini-tumors to guide treatment for aggressive prostate cancer
We will grow tiny, patient-derived mini-tumors in the lab to test which treatments work best for men with aggressive or metastatic prostate cancer.
-
Combining radiotherapy or surgery with intense hormone therapy for advanced prostate cancer
This study is testing if combining surgery or radiation with strong hormone therapy can help men with newly diagnosed advanced prostate cancer feel better and live longer.
-
SRT for bone and lymph node metastases in advanced prostate cancer
This trial tests whether treating multiple metastatic lesions with stereotactic radiotherapy can prolong pain control and prevent complications in men with advanced, treatment‑refractory prostate cancer.
-
Fezolinetant to reduce hot flashes in men on androgen-deprivation therapy
This trial will test whether taking fezolinetant once daily for 4 weeks reduces how often and how severe hot flashes are in men with prostate cancer who are on androgen-deprivation therapy.
-
New hormone therapy plus PSMA PET/CT–guided local treatment for metastatic hormone‑sensitive prostate cancer
This trial will test whether adding local treatments guided by PSMA PET/CT to standard hormone therapy helps men with newly diagnosed metastatic hormone‑sensitive prostate cancer.
-
Evaluating imaging response biomarkers in advanced prostate cancer treatment
This study is testing a new imaging method to see if a specific treatment for advanced prostate cancer can help doctors spot tumor growth early and adjust treatment when needed.
-
Investigating the impact of diet on African American and white men with prostate cancer on hormone therapy
This study is testing if a special diet can help African American and white men with prostate cancer on hormone therapy lose weight and improve heart health.
-
Evaluating prostate cancer using FAPI PET/MRI scans
This study is testing if a special type of scan can help doctors better diagnose and monitor prostate cancer in patients who already have the disease.
Related topics
Quick answers
How many Prostate Cancer Metastatic Disease clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (5 trials), France (2 trials), China (2 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.